Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
-
Field
-
20.02.2026, Academic staff Full-Time | TV-L E13 | ERC-funded for to 5 years | Focus on developing prompt-based next-generation AI systems for radiotherapy target volume definition Join an ERC-funded
-
Position Qualification Position Summary Postdoctoral Research Associate – Computational Medical Physics / Adaptive Radiotherapy The Department of Radiation Oncology at the University of Nebraska Medical
-
of neurovascular and neurocognitive changes after radiotherapy of childhood brain tumours, as per May 1, 2026 or as soon as possible thereafter (after agreement). The working place for the postdoc will be the Danish
-
Physics / Adaptive Radiotherapy The Department of Radiation Oncology at the University of Nebraska Medical Center (UNMC) is seeking applications for a Postdoctoral Research Associate position. The research
-
°C, is applied in combination with radiotherapy and/or chemotherapy to improve clinical outcome. In recent years, the ability of hyperthermia to dramatically enhance tumour control rates and even
-
Research Scholarship of Post-Doctoral Research for the scientific area of Chemistry - IST/2025/BL103
Conjugates for Targeted Chemotherapy and Radiotherapy Duration: 12 months Maximum Duration Including Renewals: 24 months Objectives Design and synthesize optimized FAP binding proteins possessing varying
-
goal. About the research project Hyperthermia therapy, i.e heating of tumour tissue in the range of 40–44°C, is applied in combination with radiotherapy and/or chemotherapy to improve clinical outcome
-
In Radiotherapy (DESIRE). The position is a full-time position for a fixed term of 3 years. It is expected that the time is divided approximately equally between the two functions in the AIM@CANCER
-
Lives with Linear Accelerators) project, which aims to leverage technologies developed for particle physics, computer vision and robotics into a novel end-to-end radiotherapy system as an essential
-
of myeloid populations in response to radiotherapy and immunotherapy, and on leveraging this knowledge to engineer precision nanotherapeutics that reprogram their behavior. By integrating molecular engineering